Rocket


News + Filings
Key Docs
Charts
Ownership

 
 
BANCO SANTANDER-CHILE (SAN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.86 Metrics
OS:
Market cap:
Net cash:
EV:

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)
Date FiledTypeDescription
04/28/2021 GN Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER
04/28/2021 GN Sanofi poursuit sa trajectoire de croissance. Forte hausse du BNPA des activités(1) au T1 2021 à TCC
04/26/2021 GN Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial
04/26/2021 GN Un essai de phase III montre que le nirsevimab protège les nourrissons en bonne santé contre les infections causées par le virus respiratoire syncytial
04/23/2021 GN New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years
04/23/2021 GN De nouvelles analyses des données relatives à Dupixent?? (dupilumab) confortent son profil de sécurité et d'efficacité à long terme chez les patients att...
04/19/2021 GN European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma


Financial Summary   (All financials)
No report was found.
Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy